Target intelligence / Profile preview

Bifidobacterium animalis subsp. lactis (B. lactis)

Target
B. lactis
Molecular classification
Other (Gram-positive probiotic bacterium), Family: Bifidobacteriaceae, Genus: Bifidobacterium, Species/Subspecies: Bifidobacterium animalis subsp. lactis
01

Overview

Bifidobacterium animalis subsp. lactis is a robust, gram-positive lactic acid bacterium found in the human colon with notable resilience against oxygen, acidity, and temperature. It ferments glucose to produce lactic and acetic acids, supporting a healthy gut microbiome. Widely used as a probiotic in dairy products and supplements, B. lactis promotes digestive health, improves immune defense, helps maintain gut barrier integrity, and demonstrates beneficial effects in conditions such as IBS, constipation, diarrhea, metabolic syndrome, and some inflammatory diseases. Its common commercial strains, such as BB-12® and HN019, are extensively clinically studied. While not a molecular therapeutic target, it is a functional microbe administered for health support; its clinical efficacy and taxonomy have undergone refinement, currently classified as a subspecies of Bifidobacterium animalis.

Other names
Bifidobacterium lactisBifidobacterium animalis subsp. lactisB. lactisBifidobacterium animalis lactisBB-12®HN019Bl-04®Bi-07®BLa80
02

Mechanism of action

Colonizes the gut to confer health benefits. Produces lactic and acetic acid, lowering colonic pH to inhibit pathogens. Strengthens intestinal barrier and modulates immune function (promoting regulatory T cells, increasing beneficial antibodies). Competes with and inhibits growth of pathogenic organisms, viruses, and bacteria. Enhances metabolic functions (improves glucose tolerance, reduces fat accumulation).

03

Biological functions

Promotes gut health and maintains gut microbiotaFerments sugars (produces lactic and acetic acid)Supports immune modulation and anti-inflammatory effectsEnhances intestinal barrier functionCompetes with pathogens and inhibits infectionsAids in digestion and nutrient absorptionModulates gut-brain axis and may reduce stress
04

Disease associations

Infection (prevents gastrointestinal infections, mitigates antibiotic-associated diarrhea)Inflammation (ameliorates gut inflammation, may assist in ulcerative colitis)Metabolic syndrome, obesity, insulin resistanceIrritable bowel syndrome (IBS), constipationPotential role in celiac disease, food allergy, and colicMay reduce respiratory infection severity
05

Safety considerations

Generally recognized as safe for most individualsPossible risks include infections in immunocompromised patients (rare)No major documented adverse effects in healthy populations; strain-specific safety profiles may vary
06

Interacting drugs

Yogurt

3 more in the full profile.

07

Biomarkers

Fecal levels of Bifidobacterium lactis (measured in stool samples)Anthropometric adiposity biomarkers (used in some research on obesity)Symptomatic improvement (e.g., changes in constipation, diarrhea, metabolic markers)

Beyond the preview

Go deeper on Bifidobacterium animalis subsp. lactis (B. lactis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bifidobacterium animalis subsp. lactis (B. lactis).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call